Literature DB >> 28199190

Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation.

Shakiba Darwish Alipour Astaneh1, Iraj Rasooli2, Seyed Latif Mousavi Gargari3.   

Abstract

Increased resistance and survival, as well as immune evasion, play a significant role in the pathogenicity of Acinetobacter baumannii. Here, we report on the adhesion of the bacterium to epithelial cells and formation of biofilm on abiotic surfaces. We identificed autotransporter (AT) genes that encode homologues (Fha-like) of the two-partner secretion system (TPS) in A.baumannii (ATCC19606) which we designate as FhaB (exoprotein) and FhaC (transporter) and demonstrate that these novel genes, are under the control of distinct regulatable promoters within either the same (FhaBC) or two distinct (FhaB and FhaC) cells. The expression of this gene in outer membrane protein (OM) showed them to be deficient in the adherence to A546 cells. FhaB is involved in hydrophobicity of A. baumannii ATCC19606 while FhaBC is associated with biofilm formation. The vaccinogenic potential of FHA-like proteins offers use of these targets as novel therapeutic strategies to limit A.baumannii associated morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28199190     DOI: 10.2741/e801

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  6 in total

1.  InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.

Authors:  Clay D Jackson-Litteken; Gisela Di Venanzio; Nguyen-Hung Le; Nichollas E Scott; Bardya Djahanschiri; Jesus S Distel; Evan J Pardue; Ingo Ebersberger; Mario F Feldman
Journal:  mBio       Date:  2022-05-31       Impact factor: 7.786

Review 2.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.

Authors:  Maria Soledad Ramirez; Robert A Bonomo; Marcelo E Tolmasky
Journal:  Biomolecules       Date:  2020-05-06

3.  MacAB-TolC Contributes to the Development of Acinetobacter baumannii Biofilm at the Solid-Liquid Interface.

Authors:  Brandon Robin; Marion Nicol; Hung Le; Ali Tahrioui; Annick Schaumann; Jean-Baptiste Vuillemenot; Delphine Vergoz; Olivier Lesouhaitier; Thierry Jouenne; Julie Hardouin; Anaïs Potron; Valérie Perrot; Emmanuelle Dé
Journal:  Front Microbiol       Date:  2022-01-13       Impact factor: 5.640

Review 4.  Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Candida Species.

Authors:  Aref Shariati; Mojtaba Didehdar; Shabnam Razavi; Mohsen Heidary; Fatemeh Soroush; Zahra Chegini
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

5.  The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Authors:  Priya Uppuluri; Lin Lin; Abdullah Alqarihi; Guanpingsheng Luo; Eman G Youssef; Sondus Alkhazraji; Nannette Y Yount; Belal A Ibrahim; Michael Anthony Bolaris; John E Edwards; Marc Swidergall; Scott G Filler; Michael R Yeaman; Ashraf S Ibrahim
Journal:  PLoS Pathog       Date:  2018-05-10       Impact factor: 6.823

6.  Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria.

Authors:  Eman G Youssef; Lina Zhang; Sondus Alkhazraji; Teclegiorgis Gebremariam; Shakti Singh; Nannette Y Yount; Michael R Yeaman; Priya Uppuluri; Ashraf S Ibrahim
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.